Applied Biosystems Group and Celera Group Third Quarter Fiscal 2008 Financial Results and Conference Call Scheduled for April 24, 2008

Business Wire, April 15, 2008

NORWALK, Conn. -- Applera Corporation announced today that it will issue fiscal 2008 third quarter financial results for its Applied Biosystems Group (NYSE:ABI) and Celera Group (NYSE:CRA) on Thursday, April 24, 2008. Results are scheduled for release before the opening of trading on the New York Stock Exchange.

Tony L. White, Chief Executive Officer, Dennis L. Winger, Chief Financial Officer, Mark Stevenson, President and Chief Operating Officer of Applied Biosystems, and Kathy Ordonez, President of Celera, will lead a conference call the same day at 11:00 a.m. (ET) to discuss these results and other matters related to the businesses. The call will be formatted to focus on each of the Applera businesses separately. The Applied Biosystems Group portion of the call will start at 11:00 a.m. (ET). The Celera Group portion of the call will start at 11:45 a.m. (ET), or immediately following the end of the Applied Biosystems portion of the call, if later.

During each segment, the management team will make prepared remarks and answer questions from securities analysts and investment professionals. Investors, securities analysts, representatives of the media and other interested parties who would like to participate should dial 617.614.6205 and enter passcode 15155917 at any time from 10:45 a.m. (ET) until the end of the call. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit the "Investors & Media" section of either www.applera.com, www.appliedbiosystems.com, or www.celera.com. A digital recording will be available approximately two hours after the completion of the conference call on April 24 until May 8, 2008. Interested parties should call 617-801-6888 and enter passcode 84165724.

About Applera Corporation

Applera Corporation consists of two operating groups. Applied Biosystems serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, such as testing required for food and pharmaceutical manufacturing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of approximately $2.1 billion during fiscal 2007. The Celera Group is a diagnostics business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and optimize patient management. Celera also commercializes a wide range of molecular diagnostic products through its strategic alliance with Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923.

Copyright(c) 2008. Applera Corporation. All Rights Reserved. Applied Biosystems, AB (Design), and Celera are registered trademarks, and Applera and Celera are trademarks of Applera Corporation or its subsidiaries in the U. S. and/or certain other countries.